We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

186 hedge funds and large institutions have $1.21B invested in Coherus Oncology in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 62

13% more call options, than puts

Call options by funds: $3.88M | Put options by funds: $3.45M

2.07% more ownership

Funds ownership: 103.68% → 105.75% (+2.1%)

4% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 28

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1% less funds holding

Funds holding: 188 → 186 (-2)

7% less capital invested

Capital invested by funds: $1.31B → $1.21B (-$97.4M)

Holders
186
Holders Change
-2
Holders Change %
-1.06%
% of All Funds
4.1%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
73
Reduced
62
Closed
28
Calls
$3.88M
Puts
$3.45M
Net Calls
+$434K
Net Calls Change
-$3.65M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$37.3M
2
Ameriprise
Ameriprise
Minnesota
+$34.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
JP Morgan Chase
JP Morgan Chase
New York
+$12.3M
5
Invesco
Invesco
Georgia
+$11.3M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$39.4M
2
N
Nuveen
North Carolina
-$12.9M
3
HRCM
Hawk Ridge Capital Management
California
-$11.8M
4
Holocene Advisors
Holocene Advisors
New York
-$10.7M
5
RCMNY
Rubric Capital Management (New York)
New York
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
51
Pictet Asset Management (UK)
United Kingdom
$3.36M +$1.75M +94,900 +85%
TRSOTSOK
52
Teachers Retirement System of the State of Kentucky
Kentucky
$3.2M +$992K +53,700 +37%
ACM
53
Atika Capital Management
New York
$3.16M – – –
Acadian Asset Management
54
Acadian Asset Management
Massachusetts
$3.15M +$3.59M +194,457 New
PIM
55
Platinum Investment Management
Australia
$2.86M +$292K +15,795 +10%
CS
56
Credit Suisse
Switzerland
$2.83M -$2M -108,438 -38%
PPA
57
Parametric Portfolio Associates
Washington
$2.71M +$1.77M +95,588 +134%
Los Angeles Capital Management
58
Los Angeles Capital Management
California
$2.68M +$1.18M +63,781 +63%
EAM
59
Erste Asset Management
Austria
$2.56M – – –
Two Sigma Investments
60
Two Sigma Investments
New York
$2.56M -$9.17M -496,281 -76%
Jacobs Levy Equity Management
61
Jacobs Levy Equity Management
New Jersey
$2.53M -$2.06M -111,424 -42%
GTC
62
Ghost Tree Capital
New York
$2.43M -$5.17M -280,000 -65%
Adage Capital Partners
63
Adage Capital Partners
Massachusetts
$2.43M -$1.39M -75,000 -33%
CEP
64
Chicago Equity Partners
Illinois
$2.39M -$3.04M -164,296 -53%
AA
65
ALPS Advisors
Colorado
$2.34M +$54K +2,924 +2%
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$2.31M +$1.53M +82,712 +138%
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$2.26M -$1.23M -66,424 -32%
KOCAA
68
Knights of Columbus Asset Advisors
Connecticut
$2.24M +$1.29M +70,089 +103%
GAM
69
Gotham Asset Management
New York
$2.21M +$259K +14,012 +11%
JGC
70
J. Goldman & Co
New York
$2.18M -$31.2K -1,687 -1%
Massachusetts Financial Services
71
Massachusetts Financial Services
Massachusetts
$2.16M +$389K +21,050 +19%
PFC
72
Phocas Financial Corp
California
$2.11M +$301K +16,311 +14%
WCM Investment Management
73
WCM Investment Management
California
$1.97M +$2.25M +121,554 New
Mirae Asset Global Investments
74
Mirae Asset Global Investments
South Korea
$1.93M -$927K -50,181 -30%
NAM
75
Nexpoint Asset Management
Texas
$1.9M -$137K -7,440 -6%
1 2
3
4 5

CHRS Hedge Fund Activity: Q1 2020 in Review

186 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2020, worth a combined $1.21B — down 7.4% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new CHRS positions and 28 closed out — a net gain of 1 holder — while 73 added to existing stakes and 62 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $37.3M. The largest seller was Lord, Abbett & Co, cutting an estimated $39.4M.

  • 186 institutional investors held Coherus Oncology (CHRS) as of Q1 2020, down from 188 in Q4 2019.
  • Funds reported $1.21B of Coherus Oncology stock for Q1 2020, down 7.4% quarter-over-quarter.
  • 29 funds opened new Coherus Oncology positions in Q1 2020 and 28 closed out, a net change of +1 holder.
  • The largest Coherus Oncology buyer in Q1 2020 was Consonance Capital Management, an estimated $37.3M added.
  • The largest Coherus Oncology seller in Q1 2020 was Lord, Abbett & Co, an estimated $39.4M sold.

Based on aggregated 13F filings for Q1 2020.